Frank Rimerman Advisors LLC Has $260,000 Stake in Centene Co. (NYSE:CNC)

Frank Rimerman Advisors LLC trimmed its position in shares of Centene Co. (NYSE:CNC) by 28.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,296 shares of the company’s stock after selling 1,687 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Centene were worth $260,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Stratos Wealth Partners LTD. increased its position in shares of Centene by 4.1% during the fourth quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock valued at $248,000 after purchasing an additional 163 shares during the period. Capital Advisors Ltd. LLC boosted its stake in Centene by 75.3% in the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after buying an additional 177 shares in the last quarter. Private Trust Co. NA boosted its stake in Centene by 23.7% in the 4th quarter. Private Trust Co. NA now owns 956 shares of the company’s stock valued at $58,000 after buying an additional 183 shares in the last quarter. Howard Capital Management Inc. boosted its stake in Centene by 5.4% in the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company’s stock valued at $218,000 after buying an additional 184 shares in the last quarter. Finally, Intellectus Partners LLC boosted its stake in Centene by 2.8% in the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company’s stock valued at $438,000 after buying an additional 200 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Centene news, Director Thomas Greco purchased 17,000 shares of the stock in a transaction on Wednesday, December 18th. The stock was bought at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the acquisition, the director now directly owns 19,309 shares of the company’s stock, valued at $1,153,712.75. The trade was a 736.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on CNC. StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Barclays boosted their price objective on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research note on Friday, December 13th. Argus lowered Centene from a “buy” rating to a “hold” rating in a research note on Thursday, February 6th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Centene in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company reduced their price objective on Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $79.92.

Centene Trading Up 1.9 %

NYSE CNC opened at $59.28 on Tuesday. The stock has a 50-day simple moving average of $60.53 and a 200 day simple moving average of $63.60. The company has a market capitalization of $29.41 billion, a PE ratio of 9.50, a P/E/G ratio of 0.80 and a beta of 0.40. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59.

Centene (NYSE:CNC) last released its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. The business had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The firm’s revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.45 earnings per share. Research analysts forecast that Centene Co. will post 6.86 EPS for the current year.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.